Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | ESR1 | P03372 | 5/20 | 0.35 |
| ▸ | ESR2 | Q92731 | 4/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.32 |
| ▸ | ABCC1 | P33527 | 1/20 | 0.32 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.32 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28427264 | 0.91 | GAA (0.45) | GAAESR1ESR2TDP1L3MBTL1 | |
| SCHEMBL19219097 | 0.88 | PPARG (0.38) | GAAESR1ESR2MEN1KMT2A | |
| SCHEMBL28427265 | 0.81 | GAA (0.44) | GAAESR1ESR2TDP1L3MBTL1 | |
| SCHEMBL18517054 | 0.81 | GAA (0.60) | GAATDP1KMT2AALDH1A1TSHR | |
| SCHEMBL9191296 | 0.80 | GAA (0.64) | GAAESR1ALDH1A1 | |
| SCHEMBL8098842 | 0.79 | GAA (0.60) | GAAESR1ESR2TDP1L3MBTL1 | |
| SCHEMBL9319774 | 0.77 | GAA (0.48) | GAA | |
| SCHEMBL9319431 | 0.76 | GAA (0.62) | GAAMEN1KMT2AALDH1A1 | |
| SCHEMBL13510740 | 0.71 | GAA (0.59) | GAAMEN1KMT2AALDH1A1TSHR | |
| SCHEMBL8705661 | 0.70 | ALDH1A1 (0.47) | GAAESR1ESR2L3MBTL1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3810621-B1 | 3-PHENYL-BENZOFURAN-2-ONE DIPHOSPHATE DERIVATIVES AS STABILIZERS | BASF SE (DE) | 2024-08-07 | — | — | EP | disclosed |
| US-11767338-B2 | 3-phenyl-benzofuran-2-one diphosphate derivatives as stabilizers | BASF SE (DE) | 2023-09-26 | — | — | US | disclosed |
| US-11767338-B2 | 3-phenyl-benzofuran-2-one diphosphate derivatives as stabilizers | BASF SE (DE) | 2023-09-26 | — | — | US | disclosed |
| US-11767338-B2 | 3-phenyl-benzofuran-2-one diphosphate derivatives as stabilizers | BASF SE (DE) | 2023-09-26 | — | — | US | disclosed |
| US-20210253617-A1 | 3-PHENYL-BENZOFURAN-2-ONE DIPHOSPHATE DERIVATIVES AS STABILIZERS | BASF SCHWEIZ AG (CH) | 2021-08-19 | — | — | US | disclosed |
| US-20210253617-A1 | 3-PHENYL-BENZOFURAN-2-ONE DIPHOSPHATE DERIVATIVES AS STABILIZERS | BASF SCHWEIZ AG (CH) | 2021-08-19 | — | — | US | disclosed |
| EP-3810621-A1 | 3-PHENYL-BENZOFURAN-2-ONE DIPHOSPHATE DERIVATIVES AS STABILIZERS | BASF SE (DE) | 2021-04-28 | — | — | EP | disclosed |
| CN-112292382-A | 3-phenylbenzofuran-2-one diphosphate derivatives as stabilizers | 巴斯夫欧洲公司 | 2021-01-29 | — | — | CN | disclosed |
| EP-3428228-B1 | 3-PHENYL-BENZOFURAN-2-ONE DERIVATIVES CONTAINING PHOSPHORUS AS STABILIZERS | BASF SE (DE) | 2020-11-25 | — | — | EP | disclosed |
| EP-3428228-B1 | 3-PHENYL-BENZOFURAN-2-ONE DERIVATIVES CONTAINING PHOSPHORUS AS STABILIZERS | BASF SE (DE) | 2020-11-25 | — | — | EP | disclosed |
| US-20170066905-A1 | 3-PHENYL-BENZOFURAN-2-ONE DERIVATIVES CONTAINING PHOSPHORUS AS STABILIZERS | BASF SE (DE) | 2017-03-09 | — | — | US | disclosed |
| US-20170066905-A1 | 3-PHENYL-BENZOFURAN-2-ONE DERIVATIVES CONTAINING PHOSPHORUS AS STABILIZERS | BASF SE (DE) | 2017-03-09 | — | — | US | disclosed |
| US-20170066905-A1 | 3-PHENYL-BENZOFURAN-2-ONE DERIVATIVES CONTAINING PHOSPHORUS AS STABILIZERS | BASF SE (DE) | 2017-03-09 | — | — | US | disclosed |
| WO-2017025431-A1 | 3-PHENYL-BENZOFURAN-2-ONE DERIVATIVES CONTAINING PHOSPHORUS AS STABILIZERS | BASF SE (DE) | 2017-02-16 | — | — | WO | disclosed |
| WO-2017025431-A1 | 3-PHENYL-BENZOFURAN-2-ONE DERIVATIVES CONTAINING PHOSPHORUS AS STABILIZERS | BASF SE (DE) | 2017-02-16 | — | — | WO | disclosed |
| EP-3107959-A1 | 3-PHENYL-BENZOFURAN-2-ONE DERIVATIVES CONTAINING PHOSPHORUS AS STABILIZERS | BASF SE (DE) | 2016-12-28 | — | — | EP | disclosed |
| WO-2016020322-A1 | 3-PHENYL-BENZOFURAN-2-ONE DIPHOSPHITE DERIVATIVES AS STABILIZERS | BASF SE (DE) | 2016-02-11 | — | — | WO | disclosed |
| WO-2016020322-A1 | 3-PHENYL-BENZOFURAN-2-ONE DIPHOSPHITE DERIVATIVES AS STABILIZERS | BASF SE (DE) | 2016-02-11 | — | — | WO | disclosed |
| WO-2015121445-A1 | 3-PHENYL-BENZOFURAN-2-ONE DERIVATIVES CONTAINING PHOSPHORUS AS STABILIZERS | BASF SE (DE) | 2015-08-20 | — | — | WO | disclosed |
| WO-2015121445-A1 | 3-PHENYL-BENZOFURAN-2-ONE DERIVATIVES CONTAINING PHOSPHORUS AS STABILIZERS | BASF SE (DE) | 2015-08-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170066905-A1 | 3-PHENYL-BENZOFURAN-2-ONE DERIVATIVES CONTAINING PHOSPHORUS AS STABILIZERS | FIP1L1, PPM1F, IK | GAA 2496/4885ESR1 717/4885ESR2 1960/4885 |
| US-20210253617-A1 | 3-PHENYL-BENZOFURAN-2-ONE DIPHOSPHATE DERIVATIVES AS STABILIZERS | DHPS, PIR, NQO1 | GAA 1606/4885ESR1 1158/4885ESR2 2292/4885 |
| US-11767338-B2 | 3-phenyl-benzofuran-2-one diphosphate derivatives as stabilizers | DHPS, PIR, NQO1 | GAA 1606/4885ESR1 1158/4885ESR2 2292/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.